ArticleBMC cancer2024

Efficacy and safety of Anlotinib based neoadjuvant chemotherapy for locally advanced triple negative breast cancer (TNBC).

Kuojun Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.